1. Renal Cluster Drug Development Pipeline Review, 2017 Published: May 2017 Single User PDF: US$ 3995 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.sales@reportsandreports.com 1 © ReportsnReports.com / Contact sales@reportsandreports.com

2. Renal Cluster Drug Development Pipeline Review, 2017 The Market Research Report on Renal Cluster Pipeline therapeutics development states the symptoms for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection. The Renal Cluster Therapeutic Development Pipeline Report provides comprehensive information on the therapeutics under development, and key players involved in therapeutic development for features dormant and discontinued projects.Renal Cluster Therapeutic Development Pipeline Report Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. There are a total of 39 products in development for this indication, by 28 companies and five academic institutions. Access Complete Report at: http://www.reportsnreports.com/reports/1001385-renal-cluster-drug- development-pipeline-review-2017.html.http://www.reportsnreports.com/reports/1001385-renal-cluster-drug- development-pipeline-review-2017.html Offers from 10th May 2017 to 2nd June 2017 All reports priced >=1,000 – 20% Discount – Single User ; 25% Discount – Global Site License. Buy 2 Reports Get 1 Report Free Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 2 © ReportsnReports.com / Contact sales@reportsandreports.com

3. Renal Cluster Drug Development Pipeline Review, 2017 Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney disease include nausea, vomiting, loss of appetite, fatigue and weakness, sleep problems, hiccups and swelling of feet and ankles. There are a total of 59 products in development for this indication, by 48 companies and two academic institutions. Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood. Symptoms include drowsiness, shortness of breath, fatigue, seizures or coma in severe cases and chest pain. There are a total of 36 products in development for this indication, by 34 companies and one academic institution. A number of companies are operating in this space, with A1M Pharma alone developing multiple programs within the area. Finally, kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Due to differences between the two patients, an autoimmune reaction against the donor kidney may occur in the recipient. There are a total of 39 products in development for this indication, by 33 companies and two academic institutions. Inquire for Discount http://www.reportsnreports.com/contacts/discount.aspx?name=1001385.http://www.reportsnreports.com/contacts/discount.aspx?name=1001385 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 3© ReportsnReports.com / Contact sales@reportsandreports.com

4. Renal Cluster Drug Development Pipeline Review, 2017 Key Companies Operating in this Pipeline include: Angion Biomedica, Pharmaxis, Cellmid and Vascular Biogenics. Angion Biomedica, Apceth Biopharma, AstraZeneca, Bayer, Evotec, Novartis, Sarfez Pharmaceuticals and Vidasym. While kidney transplant rejection treatments are largely focused on immune system molecular targets such as tumor necrosis factor alpha and complement factors, a range of cellular signaling components are being pursued in the other three key indications, including the activing receptors, cyclin dependent kinases, and growth factor receptors. Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=1001385.http://www.reportsnreports.com/purchase.aspx?name=1001385 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 4© ReportsnReports.com / Contact sales@reportsandreports.com

5. Renal Cluster Drug Development Pipeline Review, 2017 Scope of the Report Which companies are the most active within the pipeline for renal cluster therapeutics? Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication? To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies? What are the most important R&D milestones and data publications to have happened in the field of renal cluster therapeutics? Buy a Copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=1001385.http://www.reportsnreports.com/purchase.aspx?name=1001385 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. sales@reportsandreports.com 5 © ReportsnReports.com / Contact sales@reportsandreports.com5

6. About ReportsnReports ReportsnReports.comReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Contact: Ritesh Tiwari Maharashtra, India. Tel: +1-888-391-5441 sales@reportsnreports.com 6© ReportsnReports.com / Contact sales@reportsandreports.com